Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.

Since optimal rates of factor IX activation by factor XIa require the presence of calcium ions and the heavy chain of the enzyme as well as the active-site-containing light chain, we have studied the effects of calcium ions and the heavy chain on the reaction kinetics. Whereas the amidolytic activities of factor XIa and of its active-site-containing light chain were almost indistinguishable, the two enzymes behaved quite differently when factor IX was the substrate. Factor XIa was 100-fold more potent in the presence of Ca2+ than in its absence. On the contrary, the presence or absence of Ca2+ made very little difference in the case of the isolated light chain of factor XIa. Moreover, the enzymatic activity of the light chain was almost identical with that of intact factor XIa when Ca2+ was absent. Using an optimal concentration of Ca2+, we studied the activation in the presence of various concentrations of two monoclonal antibodies, one (5F4) directed against the light chain of factor XIa and the other (3C1) against its heavy chain. Analysis of 1/V vs. 1/S plots showed that whereas inhibition by 5F4 was noncompetitive, 3C1 neutralized the enzyme in a classical competitive fashion. We conclude that in the calcium-dependent activation of factor IX by factor XIa the heavy chain of the enzyme is involved in the binding of the substrate and this is essential for optimal reaction rates.

[1]  D. Sinha,et al.  Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies. , 1986, Journal of Clinical Investigation.

[2]  D. Sinha,et al.  Functional characterization of human blood coagulation factor XIa using hybridoma antibodies. , 1985, The Journal of biological chemistry.

[3]  L. Knight,et al.  Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. , 1984, The Journal of clinical investigation.

[4]  D. Sinha,et al.  Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX. , 1984, The Journal of clinical investigation.

[5]  R. Colman,et al.  Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay. , 1984, Blood.

[6]  J. Griffin,et al.  Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI. , 1983, The Journal of biological chemistry.

[7]  S. Bajaj.  Cooperative Ca2+ binding to human factor IX. Effects of Ca2+ on the kinetic parameters of the activation of factor IX by factor XIa. , 1982, The Journal of biological chemistry.

[8]  J. Miletich,et al.  The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. , 1980, Analytical biochemistry.

[9]  W. Cleland,et al.  Statistical analysis of enzyme kinetic data. , 2006, Methods in enzymology.

[10]  W. Gerhard,et al.  The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus. , 1979, Molecular immunology.

[11]  K. Fujikawa,et al.  The role of serine proteases in the blood coagulation cascade. , 1979, Advances in enzymology and related areas of molecular biology.

[12]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[13]  K. Kurachi,et al.  Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor). , 1977, Biochemistry.

[14]  Y. Nemerson,et al.  Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor. , 1977, The Journal of biological chemistry.

[15]  J. Griffin,et al.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. , 1977, The Journal of biological chemistry.

[16]  E. Davie,et al.  Isolation and characterization of bovine factor XI (plasma thromboplastin antecedent). , 1977, Biochemistry.

[17]  E. Davie,et al.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. , 1977, Biochemistry.

[18]  S. Cha,et al.  Tight-binding inhibitors-I. Kinetic behavior. , 1975, Biochemical pharmacology.

[19]  K. Fujikawa,et al.  The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). , 1974, Biochemistry.

[20]  G. Ashwell,et al.  Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins. , 1971, The Journal of biological chemistry.

[21]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[22]  R. R. Proctor,et al.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. , 1961, American journal of clinical pathology.

[23]  R. Rosenthal,et al.  New Hemophilia-like Disease Caused by Deficiency of a Third Plasma Thromboplastin Factor.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[24]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .